Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01557595 · ClinicalTrials.gov registry record · NA
Blue Wavelength Light-blocking Glasses in ADHD-Insomnia
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01557595 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 22 participants.
The verdict
NCT01557595, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Patients with ADHD often report staying up late on the computer, watching TV, or using other electronic devices, all strong emitters of blue light which may be contributing to the delayed sleep onset times seen in some of these patients. Evening use of polarizing glasses which filter out blue light may decrease the contribution of environmental light late at night to delayed bedtime. This is a treatment that Dr. Fargason uses when patients do not want to use sleep medication to help them fall asleep. The purpose of this study is to evaluate the effectiveness of this treatment by use of sleep diaries and sleep questionnaires.
Interventions
- DEVICE Polarized glasses designed to filter out blue light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01557595
The ClinicalTrials.gov registry entry for NCT01557595 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Polarized glasses designed to filter out blue light is the first listed.
NCT01557595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01557595 about?
NCT01557595 is a clinical study titled "Blue Wavelength Light-blocking Glasses in ADHD-Insomnia". Patients with ADHD often report staying up late on the computer, watching TV, or using other electronic devices, all strong emitters of blue light which may be contributing to the delayed sleep onset times seen in some of these patients. Evening use of polarizing glasses which filter out blue light ...
What is the current status of trial NCT01557595?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2011-09. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01557595?
The interventions under investigation include: Polarized glasses designed to filter out blue light (DEVICE).
Who is sponsoring clinical trial NCT01557595?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.